WST) reported revenue ahead of Wall Street’s expectations in Q1 CY2026, with sales up 21% year on year to $844.9 million ... Is now the time to buy WST? Find out in our full research report (it’s free for active Edge members).
Healthcare products company West Pharmaceutical Services (NYSE. WST) will be reporting earnings this Thursday morning. Here’s what to expect ... West Pharmaceutical Services rarely misses Wall Street’s revenue estimates ... WHILE YOU’RE HERE ... Every single day ... .
Healthcare products company West Pharmaceutical Services (NYSE. WST) will be reporting earnings this Thursday before market hours. Here’s what to look for ... Adjusted earnings are expected to come in at $1.83 per share ... More News. ViewMore ... Via MarketBeat ... .